Hepatocellular carcinoma (HCC) is the primary liver cancer that has shown a high incidence
and mortality rate worldwide among several types of cancers. A large variety of …

The effectiveness of chemotherapy in hepatocellular carcinoma (HCC) is restricted by
chemo-resistance and systemic side effects. To improve the efficacy and safety of …

Hepatocellular carcinoma (HCC) is recognized as a global health issue accounting for
millions of deaths every year. Surgery, liver ablation, and embolization therapy are amongst …

Introduction Hepatocellular carcinoma (HCC) is a major health problem worldwide.
Conventional therapies covering either chemotherapy or combination therapy still have sub …

Hepatocellular carcinoma (HCC), due to the lack of efficient diagnostic methods and short of
available treatments, becomes the third main cause of cancer deaths. Novel treatments for …

Hepatocellular carcinoma (HCC) is among the primary drivers of cancer-related death
globally, owing to the ineffectiveness of treatments in intermediate and terminal stages—an …

Hepatocellular carcinoma (HCC) is the most common primary liver cancer and poses a
major challenge to global health due to its high morbidity and mortality. Conventional …

Hepatocellular carcinoma (HCC) has a fairly high morbidity and is notoriously difficult to treat
due to long latent period before detection, multidrug resistance and severe drug-related …

Hepatocellular carcinoma (HCC) is the most common primary liver cancer with high
morbidity and mortality worldwide. Chemotherapy is recommended to patients with …

Liver cancer is considered one of the deadliest diseases with one of the highest disease
burdens worldwide. Among the different types of liver cancer, hepatocellular carcinoma is …